FY2022 Half Year Update
Filed with ASX · · 25 pages · English
This presentation (Presentation) has been prepared solely for informational purposes by Lumos Diagnostics Holdings Limited (Company). The information contained in this document (“Document”) has been prepared by Lumos Diagnostics Holdings Limited (referred to as “Lumos” or “Company”). This Document is current as at the date of this Document and should be read in conjunction with other Lumos periodi
Lumos Diagnostics Holdings Ltd. on 6ix
Earlier from Lumos Diagnostics
- Lumos Diagnostics FY22 First Half Year Results
- Change To Lumos Board
- Victorian Government Intent for Lumos Manufacturing Hub
- Over 100 Pharmacies in Liverpool UK Launch FebriDx Service
- Lumos Provides ViraDx and FebriDx Regulatory Update
Later from Lumos Diagnostics
- FebriDx Update - Brazil Market Authorisation & New Study
- Operational Review & Management Reorganisation
- Operational Update and Accelerated Entitlement Offer
- Target Market Determination
- Successful Completion of Institutional Entitlement Offer
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics